SAMANTHA DORMAN: Open Payments
NPI 1417209644 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 36 payments from 12 companies in 2025. Trend: 2023 $188 · 2024 $937 · 2025 $683
Food & beverage: $683
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $144 |
| Braeburn Inc. | 4 | $90 |
| Lundbeck LLC | 3 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Indivior Inc. | 3 | $68 |
| Supernus Pharmaceuticals, Inc. | 2 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Abbott Laboratories | 1 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
Products named: VRAYLAR, REXULTI, BRIXADI, SUBLOCADE, ABILIFY MAINTENA, Qelbree, Auvelity, FREESTYLE LIBRE 3.
Industry payments across AZ — which companies pay providers there.
